8 January 2024
Latham Advises Rhythm on Agreement to Acquire Global Rights to Oral MC4R Agonist LB54640 From LG Chem
Advising firms
Deal team
15 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Steven Chinowsky Lead | Latham & Watkins LLP | Partner | licensing | Not stated |
| Peter Handrinos Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Elizabeth Slawsby Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Oliver Mobasser | Latham & Watkins LLP | Associate | licensing | Not stated |
| Ami Sodha | Latham & Watkins LLP | Associate | licensing | Not stated |
| Mandy Reeves | Latham & Watkins LLP | Partner | antitrust | Not stated |
| Héctor Armengod | Latham & Watkins LLP | Partner | antitrust | Not stated |
| Patrick English | Latham & Watkins LLP | Counsel | antitrust | Not stated |
| Jennifer Yoon | Latham & Watkins LLP | Partner | public company matters | Not stated |
| Jenna Cooper | Latham & Watkins LLP | Partner | public company matters | Not stated |
| Hamna Ahmad | Latham & Watkins LLP | Associate | public company matters | Not stated |
| Naseem Faqihi Alawadhi | Latham & Watkins LLP | Associate | public company matters | Not stated |
| Kirt Switzer | Latham & Watkins LLP | Partner | tax | Not stated |
| Derek Gumm | Latham & Watkins LLP | Associate | tax | Not stated |
| Darryl Steensma | Latham & Watkins LLP | Counsel | patent diligence | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Rhythm Pharmaceuticals, Inc.Buy-side
- Counterparties
- LG Chem Life Sciences (Sell-side)